ORIGINAL RESEARCH article
Front. Public Health
Sec. Aging and Public Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1616232
Trends and Forecasts of the Prevalence and Mortality of Alzheimer's Disease and Other Dementias in China
Provisionally accepted
Mingxuan Hou1,2
Ling Yang1*- 1Shanghai Fourth People's Hospital, Shanghai, China
- 2Shanghai University of Sport, Shanghai, Shanghai Municipality, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
As one of the most aging populations in the world, China has experienced a continuous increase in the disease burden of Alzheimer's Disease (AD) and other dementia (ADRD). This study aims to analyze the trends in prevalence and mortality rates of AD and related dementia in China from 1990 to 2021 and to predict the disease burden by 2040.Data was extracted from the Global Burden of Disease Study 2021 (GBD 2021). Joinpoint regression was used to identify significant changes in trends, while Age-Period-Cohort (APC) models were applied to disentangle age, period, and cohort effects. Bayesian Age-Period-Cohort (BAPC) modeling was used for future projections. In addition, we conducted a risk factor analysis of ADrelated mortality attributable to smoking, high body mass index (BMI), and high fasting plasma glucose (FPG).In 2021, the age-standardized prevalence of AD and other dementia in China was 1194 per 100,000 (95% CI: 1018-1383), and the mortality rate was 35 per 100,000 (95% CI: 9-93). The disease burden was significantly higher in females compared to males (prevalence: females 1559 per 100,000 vs. males 846 per 100,000). Joinpoint analysis showed a significant increase in both prevalence and mortality rates after 2019 (male APC = 2.81%, female APC = 3.76%). Risk factor analysis highlighted obesity (AAPC = 9.87%) as the leading contributor to AD mortality in China, surpassing global averages. The BAPC model predicted that by 2040, the prevalence in females would increase to 1180 per 100,000, while the mortality rate for males would stabilize at 17.6 per 100,000. Our results indicate a substantial increase in disease burden, underscoring the urgent need for strategic interventions and resource allocation to mitigate the future impact of dementia-related conditions in China.The disease burden of AD and related dementia in China continues to rise, necessitating enhanced early screening, optimized healthcare resource allocation, and targeted intervention strategies for high-risk female populations.
Keywords: Alzheimer's disease, Dementia, Prevalence, Mortality, prediction, China
Received: 22 Apr 2025; Accepted: 31 May 2025.
Copyright: © 2025 Hou and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ling Yang, Shanghai Fourth People's Hospital, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.